Skip to content
  • Sunday, 26 July 2026
  • 4:31 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • SmolVLM2-2.2B Revolutionizes Local Video Summarization with Consumer Hardware Accessibility
Data Science & Bioinformatics

SmolVLM2-2.2B Revolutionizes Local Video Summarization with Consumer Hardware Accessibility

Evan Lee Salim Jul 10, 2026 0

A significant leap in artificial intelligence accessibility has been marked by the release of SmolVLM2-2.2B by Hugging Face on February…

Read More
Clinical Diagnostics & Pathology

Walk-in Lab Testing in West Virginia Accelerates Consumer-Driven Healthcare, Reshaping Diagnostic Access and Clinical Laboratory Models

Reynand Amr Wu May 24, 2026 0

The landscape of healthcare diagnostics is undergoing a profound transformation, with West Virginia emerging as a key region illustrating this…

Read More
Clinical Diagnostics & Pathology

Walk-in Lab Testing in West Virginia Signals a National Shift Toward Consumer-Directed Healthcare

Reynand Amr Wu May 2, 2026 0

The landscape of diagnostic services in West Virginia is undergoing a transformative shift, with the proliferation of walk-in laboratory testing…

Read More
Clinical Diagnostics & Pathology

Walk-in Lab Testing in West Virginia Accelerates Consumer-Driven Healthcare, Reshaping Diagnostic Access and Clinical Lab Models

Reynand Amr Wu Apr 3, 2026 0

The landscape of healthcare diagnostics is undergoing a profound transformation, with walk-in lab testing emerging as a pivotal force in…

Read More
Laboratory Automation & Robotics

TrumpRx.gov: A Federal Portal’s Ambitions and the Intensifying Scrutiny of Direct-to-Consumer Drug Sales

Lana Keisha Mar 31, 2026 0

As of early February, TrumpRx.gov presents a starkly minimalist facade: a stylized Oval Office portrait of the president accompanied by…

Read More
Laboratory Automation & Robotics

TrumpRx.gov: A Federal Portal Faces Scrutiny Amidst Concerns Over Direct-to-Consumer Drug Sales and Patient Safety.

Lana Keisha Mar 23, 2026 0

As of early February, the federal portal TrumpRx.gov remains in a nascent state, displaying only a stylized Oval Office portrait…

Read More
A Fresh Experiment Comes Up With a Lower Value for “Big G,” One of Physics’ Key ConstantsThe Indispensable Art of Data Hygiene: Navigating the Complexities of Messy Datasets with Python and Pandas for Robust AnalyticsTWiV 1286: Clinical Update with Dr. Daniel GriffinThe Rise of AI Agent Skill Marketplaces: A New Frontier in Autonomous AI Development and Deployment.
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ